SeaStar Medical Holding Corporation (ICU) — Financial statements
Income statement, balance sheet, and cash flow for SeaStar Medical Holding Corporation — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 1↑814.1% | 0.14 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 1↑774.8% | 0.14 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 8↓17.4% | 9↑52.4% | 6↑138.6% | 3↓9.5% | 3 | |
| General & Administrative Expenses | 6↓34.2% | 9↑10.8% | 8↑15.7% | 7↑310.9% | 2 | |
| Selling & Marketing Expenses | 0.00 | 0.00↓100.0% | 0.03 | 0.00 | 0.00 | |
| SG&A Expenses | 6↓34.2% | 9↑10.4% | 8↑16.2% | 7↑310.9% | 2 | |
| Other Expenses | 0.00 | 0.00↓100.0% | 0.20↓90.9% | 2 | 0.00 | |
| Operating Expenses | 13↓25.7% | 18↑26.5% | 14↑22.4% | 12↑160.9% | 4 | |
| Total Costs & Expenses | 13↓25.4% | 18↑26.5% | 14↑22.4% | 12↑160.9% | 4 | |
| Operating Results | ||||||
| Operating Income | -12↑31.8% | -18↓25.6% | -14↓22.4% | -12↓160.9% | -4 | |
| Depreciation & Amortization | 0.00 | 0.00↓100.0% | 14 | 0.00 | 0.00 | |
| EBITDA | -12↑50.5% | -25↓120.7% | -11↑3.6% | -12↓163.6% | -4 | |
| EBIT | -12↑50.5% | -25↑2.3% | -25↓117.6% | -12↓163.6% | -4 | |
| Interest & Other Income | ||||||
| Net Interest Income | -0.00↑97.2% | -0.14↑86.8% | -1↓71.9% | -0.63↓196.7% | -0.21 | |
| Interest Income | 0.33↑221.8% | 0.10 | 0.00↓100.0% | 0.00 | 0.00 | |
| Interest Expense | 0.33↑34.8% | 0.24↓77.4% | 1↑71.6% | 0.63↑197.2% | 0.21 | |
| Non-Operating Income | 0.00↓100.0% | 7↓38.4% | 11↑21982.0% | -0.05↑21.9% | -0.06 | |
| Other Income / Expenses | 0.03↑100.4% | -7↑41.9% | -12↓1972.8% | -0.58↓291.9% | -0.15 | |
| Income Before Tax | -12↑51.1% | -25↑5.4% | -26↓115.2% | -12↓165.2% | -5 | |
| Income Tax Expense | 0.00↑0.0% | 0.00 | 0.00↓100.0% | 0.00↑200.0% | -0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -12↑51.1% | -25↑5.3% | -26↓115.2% | -12↓165.2% | -5 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -12↑51.1% | -25↑5.3% | -26↓115.2% | -12↓165.2% | -5 | |
| Bottom-Line Net Income | -12↑51.1% | -25↑5.3% | -26↓115.2% | -12↓165.2% | -5 | |
| EPS (Basic) | -5.86↑91.2% | -66.30↑78.1% | -302.62↓29.4% | -233.80↓165.4% | -88.10 | |
| EPS (Diluted) | -5.86↑91.2% | -66.30↑78.1% | -302.62↓29.4% | -233.80↓165.4% | -88.10 | |
| Weighted Average Shares | 21↑5437.1% | 0.37↑331.9% | 0.09↑66.3% | 0.05↓0.1% | 0.05 | |
| Weighted Average Diluted Shares | 21↑5437.1% | 0.37↑331.9% | 0.09↑66.3% | 0.05↓0.1% | 0.05 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.